Aptose Biosciences Inc  

(Public, NASDAQ:APTO)   Watch this stock  
Find more results for OTC:LRUSF
5.02
+0.12 (2.45%)
Jan 30 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 4.76 - 5.14
52 week 4.44 - 9.44
Open 5.00
Vol / Avg. 3,231.00/16,072.00
Mkt cap 57.90M
P/E     -
Div/yield     -
EPS -1.65
Shares 11.70M
Beta 1.17
Inst. own 35%
Jan 13, 2015
Aptose Biosciences Inc at EBD Biotech Showcase
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -38.73% -66.09%
Return on average equity -41.50% -76.31%
Employees 19 -
CDP Score - -

Address

2 Meridian Rd
TORONTO, ON M9W 4Z7
Canada
+1-416-7981200 (Phone)
+1-416-7982200 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Aptose Biosciences Inc, formerly Lorus Therapeutics Inc., is a life sciences company. The Company is focused on the discovery, research and development of effective anticancer therapies with a safety profile. The Company has worked to establish a diverse anticancer product pipeline, with products in various stages of development ranging from pre-clinical to a completed Phase I clinical trial. Intellectual property portfolio supports its diverse product pipeline.

Officers and directors

William G. Rice Ph.D. Chairman of the Board, President, Chief Executive Officer
Bio & Compensation  - Reuters
Gregory K. Chow Chief Financial Officer, Senior Vice President
Bio & Compensation  - Reuters
Elizabeth Williams Finance Director, IR Contact Officer
Bio & Compensation  - Reuters
Avanish Vellanki Senior Vice President, Chief Business Officer
Bio & Compensation  - Reuters
Stephen B. Howell M.D. Chief Medical Officer
Age: 69
Bio & Compensation  - Reuters
Erich M. Platzer M.D., Ph.D. Director
Bio & Compensation  - Reuters
Denis R. Burger Ph.D. Independent Director
Age: 69
Bio & Compensation  - Reuters
Bradley Thompson Independent Director
Bio & Compensation  - Reuters
Mark D. Vincent M.D. Independent Director
Bio & Compensation  - Reuters
Warren Whitehead Independent Director
Bio & Compensation  - Reuters